Author:
Roche-Lima Abiel,Rosado-Quiñones Angélica M.,Feliu-Maldonado Roberto A.,Figueroa-Gispert María Del Mar,Díaz-Rivera Jennifer,Díaz-González Roberto G.,Carrasquillo-Carrion Kelvin,Nieves Brenda G.,Colón-Lorenzo Emilee E.,Serrano Adelfa E.
Abstract
Abstract
Purpose
Antimalarial drug resistance is a global public health problem that leads to treatment failure. Synergistic drug combinations can improve treatment outcomes and delay the development of drug resistance. Here, we describe the implementation of a freely available computational tool, Machine Learning Synergy Predictor (MLSyPred©), to predict potential synergy in antimalarial drug combinations.
Methods
The MLSyPred© synergy prediction method extracts molecular fingerprints from the drugs’ biochemical structures to use as features and also cleans and prepares the raw data. Five machine learning algorithms (Logistic Regression, Random Forest, Support vector machine, Ada Boost, and Gradient Boost) were implemented to build prediction models. Implementation and application of the MLSyPred© tool were tested using datasets from 1540 combinations of 79 drugs and compounds biologically evaluated in pairs for three strains of Plasmodium falciparum (3D7, HB3, and Dd2).
Results
The best prediction models were obtained using Logistic Regression for antimalarials with the strains Dd2 and HB3 (0.81 and 0.70 AUC, respectively) and Random Forest for antimalarials with 3D7 (0.69 AUC). The MLSyPred© tool yielded 45% precision for synergistically predicted antimalarial drug combinations that were annotated and biologically validated, thus confirming the functionality and applicability of the tool.
Conclusion
The MLSyPred© tool is freely available and represents a promising strategy for discovering potential synergistic drug combinations for further development as novel antimalarial therapies.
Funder
National Institute on Minority Health and Health Disparities
National Institute of Health - RISE
National Institute of Health - NIGMS - RISE
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. World Health Organization (2021) World malaria report 2021. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240040496
2. Menard D, Dondorp A (2017) Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb Perspect Med 7:1–24. https://doi.org/10.1101/cshperspect.a025619
3. World Health Organization (2022) Global tuberculosis report 2022. Geneva: World Health Organization. https://www.who.int/publications-detail-redirect/9789240083851
4. Boshoff HIM, Warner DF, Gold B (2023) Editorial: drug-resistant Mycobacterium tuberculosis. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2023.1215294
5. Bulusu KC, Guha R, Mason DJ, Lewis RPI, Muratov E, KalantarMotamedi Y, Cokol M, Bender A (2016) Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives. Drug Discov Today 21:225–238. https://doi.org/10.1016/j.drudis.2015.09.003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献